Heterogeneity of Glucose Transport in Lung Cancer
Increased glucose uptake is a known hallmark of cancer. Cancer cells need glucose for energy production via glycolysis and the tricarboxylic acid cycle, and also to fuel the pentose phosphate pathway, the serine biosynthetic pathway, lipogenesis, and the hexosamine pathway. For this reason, glucose...
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-06-01
|
Series: | Biomolecules |
Subjects: | |
Online Access: | https://www.mdpi.com/2218-273X/10/6/868 |
id |
doaj-e02059c7aff54fe7bc88a07992c67051 |
---|---|
record_format |
Article |
spelling |
doaj-e02059c7aff54fe7bc88a07992c670512020-11-25T03:25:12ZengMDPI AGBiomolecules2218-273X2020-06-011086886810.3390/biom10060868Heterogeneity of Glucose Transport in Lung CancerCesar A. Martinez0Claudio Scafoglio1Division of Pulmonary and Critical Care Medicine, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA 90095, USADivision of Pulmonary and Critical Care Medicine, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA 90095, USAIncreased glucose uptake is a known hallmark of cancer. Cancer cells need glucose for energy production via glycolysis and the tricarboxylic acid cycle, and also to fuel the pentose phosphate pathway, the serine biosynthetic pathway, lipogenesis, and the hexosamine pathway. For this reason, glucose transport inhibition is an emerging new treatment for different malignancies, including lung cancer. However, studies both in animal models and in humans have shown high levels of heterogeneity in the utilization of glucose and other metabolites in cancer, unveiling a complexity that is difficult to target therapeutically. Here, we present an overview of different levels of heterogeneity in glucose uptake and utilization in lung cancer, with diagnostic and therapeutic implications.https://www.mdpi.com/2218-273X/10/6/868glucose metabolismglucose transportcancerlung cancertumor heterogeneity |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Cesar A. Martinez Claudio Scafoglio |
spellingShingle |
Cesar A. Martinez Claudio Scafoglio Heterogeneity of Glucose Transport in Lung Cancer Biomolecules glucose metabolism glucose transport cancer lung cancer tumor heterogeneity |
author_facet |
Cesar A. Martinez Claudio Scafoglio |
author_sort |
Cesar A. Martinez |
title |
Heterogeneity of Glucose Transport in Lung Cancer |
title_short |
Heterogeneity of Glucose Transport in Lung Cancer |
title_full |
Heterogeneity of Glucose Transport in Lung Cancer |
title_fullStr |
Heterogeneity of Glucose Transport in Lung Cancer |
title_full_unstemmed |
Heterogeneity of Glucose Transport in Lung Cancer |
title_sort |
heterogeneity of glucose transport in lung cancer |
publisher |
MDPI AG |
series |
Biomolecules |
issn |
2218-273X |
publishDate |
2020-06-01 |
description |
Increased glucose uptake is a known hallmark of cancer. Cancer cells need glucose for energy production via glycolysis and the tricarboxylic acid cycle, and also to fuel the pentose phosphate pathway, the serine biosynthetic pathway, lipogenesis, and the hexosamine pathway. For this reason, glucose transport inhibition is an emerging new treatment for different malignancies, including lung cancer. However, studies both in animal models and in humans have shown high levels of heterogeneity in the utilization of glucose and other metabolites in cancer, unveiling a complexity that is difficult to target therapeutically. Here, we present an overview of different levels of heterogeneity in glucose uptake and utilization in lung cancer, with diagnostic and therapeutic implications. |
topic |
glucose metabolism glucose transport cancer lung cancer tumor heterogeneity |
url |
https://www.mdpi.com/2218-273X/10/6/868 |
work_keys_str_mv |
AT cesaramartinez heterogeneityofglucosetransportinlungcancer AT claudioscafoglio heterogeneityofglucosetransportinlungcancer |
_version_ |
1724598258825691136 |